Interestingly, we and others have observed associations between several tyrosine kinases (i.e., BTK, Src, Tec) and AKT and ERK signaling in inflammation- and neuroinflammation-associated diseases (i.e., cancer, CML). This evidence concerns the gene BTK and chronic myelogenous leukemia, BCR-ABL1 positive.